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Children with asthma remain a problem in public health because asthma drastically 
impacts children’s daily activities, increases absenteeism in school, and causes 
difficulties in sleeping. Researchers have demonstrated that poor asthma management is 
due to a lack of education about the correct inhaler technique, and the appropriate doses 
are not inhaled. Researchers have yet established whether asthma symptoms improve 
based on the doses inhaled with or without a spacer and whether children are most likely 
to experience fewer asthma episodes or attacks if they receive professional instruction. 
The purpose of this study was to fully understand the influence of an inhalation device 
with or without a spacer in medication delivery and to understand if instruction given by 
clinicians alleviates the number of asthma episodes or attacks. The transtheoretical or 
stages of change was used to analyze an individual’s ability to act on a new healthier 
behavior. This study involved children (N = 416) aged 7 through 12 years old who 
participated in the 2015 Asthma Call-Back Survey. Quantitative cross-sectional study 
design was used to encompass information, including an interview questionnaire, a 
survey, and existing literature. A chi-square, Phi, and Cramer’s V test were used to 
address the research questions. The results of this study indicated that managing asthma 
symptoms does not depend on the number of doses inhaled with or without a spacer. 
Children are less likely to experience asthma episodes or attacks with proper professional 
education. Further exploration is needed to investigate the effectiveness of the method of 
teaching by pharmacists and other clinicians. The parents of children and clinicians may 
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Section 1: Foundation of the Study and Literature Review  
Introduction 
 Children with asthma may encounter serious health complications that may affect 
their health status, which has become a significant concern in public health. Asthma 
causes inflammation in the airways, resulting in difficulty breathing, wheezing, and 
shortness of breath. Asthma is frequently associated with respiratory infections, chest 
pressure, anxiety, rapid heart rate, and throat irritation (Denholm, Van Der Werf, & Hay, 
2020; Ehrlich et al., 2019). In the United States, more than 497,000 people are 
hospitalized annually due to asthma (Shaw et al., 2016), and according to the Centers for 
Disease Control and Prevention (CDC; 2018), there are over 6 million children under the 
age of 18 with asthma. The use of inhaled treatments has become one standard protocol 
for asthma and children (Bush, Fleming, & Saglani, 2017); however, this remains a 
concern as proper usage and effectiveness of this form of treatment may not always be 
performed correctly.  
 While the inhalation of medication remains a standard treatment, the inclusion of 
a spacer helps prevent medication loss, ensuring more of the treatment is inhaled to the 
lungs (Gillette, Rockich-Winston, Kuhn, Flesher, and Shepherd, 2016). A spacer is a tube 
that improves the inhalation of medication into the lungs (Kofman & Teper, 2018). 
Moreover, children who lack training in the proper use of the inhaler may not receive 
sufficient treatment, resulting in significantly limited asthma symptom control. The 
technique used in the inhalation of medication determines the amount of medication 
delivered to the lungs; operating the inhaler device correctly increases the likelihood of 
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receiving the proper therapeutic dose. Therefore, further study is needed to investigate the 
association between (a) the amount of the Albuterol (+ A. Sulfate or Salbutamol) inhaled 
(with or without spacers) among children in the sample population, (b) the association 
between education on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol), and 
(c) the severity of asthma attacks in children.  
 This study can promote positive social change because the results help inform the 
foundational knowledge by informing parents about the proper use of inhalation and 
making appropriate health decisions to reduce asthma incidents in children. Public health 
professionals and other clinical providers could use the research findings to educate the 
parents to increase awareness of this health issue. Positive social change may be 
accomplished through health care providers demonstrating the proper use of the 
inhalation technique while administering the medication on their patients in the 
healthcare setting. Effectively using the inhalation devices properly with a spacer may 
significantly alleviate the duration of asthma episodes and reduce emergency department 
(ED) visits.    
Problem Statement 
 Asthma remains a significant concern in the field of public health because it 
drastically impacts children’s daily activities, increases absenteeism in school, and causes 
difficulties in sleeping (Shaikh & Byrd, 2016). In the United States, an estimated 10% of 
children have asthma (Shaikh & Byrd, 2016); if left untreated, asthma symptoms can be 
worsened through poor symptom management, leading to severe health conditions. An 
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inhaler remains the standard method for delivering asthma medication into the lungs 
(Gillette et al., 2016).  
 Research has shown that some children’s inhaler techniques might be ineffectual, 
and the type of device used might affect asthma outcomes (Gillette et al., 2016). Incorrect 
inhalation technique is a significant factor for inadequate medication delivery, resulting 
in poor control of asthma symptoms (Ravikumar, Raghavendra, & Priyadarshini, 2018). 
Therefore, establishing an efficient method is crucial in selecting asthma control 
medication delivery (Gillette et al., 2016). According to Kofman and Teper (2018), 
improving the inhalation technique, such as using a spacer with inhalation delivery 
devices, increases asthma control in children. As researchers have yet to investigate if a 
certain amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without a spacer 
affects the likelihood of asthma episodes or attacks in children between the ages of 7 and 
12, there currently exists a gap in the knowledge. 
 Inhalation of medications has several positive effects in treating diseases of the 
respiratory tract (Kofman & Teper, 2018). When using the inhalation devices, patients 
need to follow several chronological steps to deliver the drugs successfully to the lungs 
(Al Ammari, Yunus, Al Ghobain, & Al Halwan, 2016). Many children with asthma 
misuse their inhaler devices, resulting in unreliable drug delivery, even after proper 
inhalation instruction (Jat, Singhal, & Guglani, 2016). Many children still misuse their 
inhaler device, even after being taught how to operate the device correctly (Shaw et al., 
2016). Özkars and Kirik (2019) added that an improper medication use technique could 
prevent the medication from reaching airways, resulting in at least limited effectiveness 
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in treating symptoms. Children’s inhalation techniques may be too imprecise to result in 
reliable drug delivery (Shaw et al., 2016). Consequently, in this study, I focused on 
investigating the association between the amounts of inhalation of Albuterol (+ A. Sulfate 
or Salbutamol) with and without spacers in children ages 7 to 12 years old with asthma.  
Purpose of the Study 
The primary purpose of this study was to examine the association between the 
amount of inhalation of Albuterol (+ A. Sulfate or Salbutamol) and the use of spacers 
among 7 to 12-year-old children with asthma. In this study, I sought to determine if the 
amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled varied with the use of spacers 
when used by children with asthma aged 7 to 12 years old suffering an asthma attack 
episode. The variables were Albuterol (+ A. Sulfate or Salbutamol) and the use of 
spacers; the population sample was children aged 7 to 12 years with asthma. The 
variables were examined to address the research questions and develop new insights into 
the current health issue to create useful and practical approaches in designing and 
implementing a prevention program, potentially leading to positive social change. 
Additionally, the study improved the knowledge of the delivery of asthma medication, 
increasing children’s awareness of the proper use and maintenance of inhalers.  
Research Questions and Hypotheses  
Research Question (RQ)1-Quantitative: What is the association between the 
amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers 
among children 7 to 12 years old? 
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H01: There is no significant statistical association between the amount of Albuterol 
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to 
12 years old.  
H1:  There is a significant statistical association between the amount of Albuterol 
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to 
12 years old. 
Research Question (RQ)2-Quantitative: What is the association between the 
number of asthma episodes or attacks with or without professional inhalation 
instruction on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in 
children 7 to 12 years old? 
H01: There is no association between the number of asthma episodes or attacks 
 with or without professional inhalation instruction on the proper delivery of 
 Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old. 
H02: There is an association between the number of asthma episodes or attacks 
with or without professional inhalation instruction on the proper delivery of 
Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old. 
Theoretical Foundation for the Study  
This study's theoretical framework was the transtheoretical model or stages of 
change (see Keshmiri et al., 2017). This theory was appropriate to this study because it 
examines an individual’s ability to act on new healthier behavior and provides strategies 
or approaches for change to guide the individual in reaching a desired health outcome 
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(Keshmiri et al., 2017). According to Keshmiri et al. (2017), participants can be at any of 




4. Action  
5. Maintenance 
6. Termination  
The individuals undergo each stage to increase compliance with inhaled 
medications. The significance is that the transtheoretical model assists individuals in 
adopting a new behavior, whether to use an inhaler with medicines to prevent asthma 
episodes or attacks among asthmatic children. The transtheoretical model guides the 
children with asthma to learn and comply with the proper use of inhalational techniques 
and interventions to achieve their desired health outcomes. The transtheoretical model is 
a valuable tool to guide and counsel participants to reach their desired health outcomes 
using the interventions published in a health program (Daniels et al., 2014). This 
particular framework comprehensively assesses behavior change and the design of 
effective interventions (Gold et al., 2016). Berhane, Biadgilign, Berhance, and Memiah 
(2015) stated that the six constructs of the model act as the model of behavior change to 
articulate how and why people alter their behaviors.   
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Nature of the Study  
The nature of this study was a cross-sectional research design data analysis that 
has been conducted using Statistical Package for the Social Sciences (v.25) Software. The 
dependent variable was the number of canisters Albuterol (+ A. Sulfate or Salbutamol). 
The independent variable was Albuterol (+ A. Sulfate or Salbutamol) with or without a 
spacer. For the second research question, the dependent variable was the duration of 
asthma episodes or attacks in children, and the independent variable was with or without 
an inhalation technique instruction given by a professional. Using quantitative research 
for this study can develop numerical data that provides meaningful new insights that 
support generalizations related to the phenomenon under study. The quantitative research 
was performed to provide statistical analysis that validated the association between two 
or more variables and measured trends or the incidence of various views.  
The quantitative research design addresses cause and effect relationships and, 
therefore, can be relied on to create predictions. Quantitative research can report credible 
statistics results to help answer the research questions. The quantitative research design 
establishes statistical numbers and associations between variables that can be described 
using figures, graphs, and inferential statistics. Further, my investigation addressed 
asthmatic children in that I was interested in understanding asthma episodes or attacks 
determined by the amount of medication inhaled with and without a spacer. In this 
research study, I focused on investigating the association of the number of canisters of 
Albuterol (+ A. Sulfate or Salbutamol) with or without a spacer used in children with 
asthma in the age group of 7 to 12 years old. Additionally, I investigated the association 
8 
 
of the duration of asthma attacks and episodes on children with asthma and whether they 
received professional instruction on how to operate an inhalation device correctly.   
Literature Search Strategy 
The literature review provided an overview of an Albuterol (+ A. Sulfate or 
Salbutamol) inhaler with and without a spacer in children ages 7 to 12 years with asthma. 
The keywords searched were spacers, inhalers, inhalation technique, medications, 
asthma, children, public health, doses, education, quality of life, respiratory disease, 
medication adherence, asthma control, asthma symptom control, asthma knowledge, 
medication nonadherence, asthma outcome, and pediatric in the databases Google 
Scholar, PubMed, and EBSCO. The keywords listed above were tailored to the scope of 
the study using the appropriate databases with peer-reviewed scholarly articles reviewed 
that were published from 2015 and 2019.  
Literature Review Related to Key Variables and/or Concepts 
Health Issue: Asthma  
Asthma is one of the concerns in public health because it develops adverse health 
effects in children. Asthma is a chronic disease, is heterogeneous, and is an inflammatory 
disease of the respiratory system (Ibrahim et al., 2019). Coughing, wheezing, chest 
tightness at night, and breathing difficulties are indicators of asthma in children (Furtado 
et al., 2019). This health issue needs to be addressed to improve and obtain the desired 
positive health outcome in the population. According to Gillette et al. (2016), about 7 
million in pediatric populations in the United States are affected by asthma.  
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Asthma leads to chronic disease in children, and it increases the number of 
hospital visits (Ahmad et al., 2018; Jat et al., 2016; Tattersall et al., 2018). Asthmatic 
children left untreated are most likely to experience several challenges in their life 
mentally and impaired quality of life (Greenlee, Winter, Fiese, & Everhart, 2019). The 
impairment to quality of life limits children's daily activities such as in sports and games, 
and they may experience difficulties interacting with family members, anxiety, and 
disrupt functionality because of the disease (Kocaaslan & Akgun Kostak, 2019). 
Understanding the factors associated with the adverse outcomes for children with asthma 
is crucial to identifying interventions and preventions to alleviate the condition's 
symptoms more effectively.  
Quality of Life for Children With Asthma  
 There are several effective treatments and interventions available to treat asthma; 
however, asthma continues to negatively impact children's quality of life when these 
treatments and interventions are not always implemented correctly. Quality of life plays a 
vital role in monitoring asthma control (Melgarejo González-Conde, Pérez-Fernández, 
Ruiz-Esteban, & Valverde-Molina, 2019). Quality of life is used as an indicator for 
children who have asthma as the condition negatively impacts their physiological 
development, drastically affecting physical, mental, and emotional health (Kocaaslan & 
Kostak, 2019). Asthmatic children may experience a lower tolerance for physical activity 
and are more likely to stay indoors than other children without asthma (Furtado et al., 
2019). Self-efficacy refers to an individual who can perform behaviors necessary to 
manage asthma symptoms and maintain a positive health outcome (Melgarejo González-
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Conde et al., 2019). Children with proper asthma education can provide care for 
themselves with minimal supervision. Professionals providing care to children with 
asthma need to comply with and understand the national guidelines to effectively 
implement an asthma management plan (McCabe, McDonald, & Lipman, 2019). 
Children with asthma tend to eliminate their extracurricular activities and be bullied 
because of their symptoms (Carey, Edds-McAfee, Martinez, Gutierrez de Blume, and 
Thornton, 2019; Kalyva, Eiser, & Papathanasiou, 2016). Poor asthma control affects the 
quality of life. For example, children may be discouraged from attending school or 
academic performance may be impacted; the parents may also need to miss work to 
provide care for their child (Carey et al., 2019; Ellis et al., 2019).  
Poor asthma control increases the rate of morbidity, limits daily activities, and 
negatively impacts children's overall health status (Quirt, Hildebrand, Mazza, Nova, and 
Kim, 2018). Children with asthma are often unable to attend school for at least two 
consecutive days more than children without asthma (Carpenter et al., 2016). Individuals 
who care for children need to provide continuous guidance to manage their asthma and 
support related decision-making.  Asthma impacts the quality of life of children in several 
ways. Therefore, it is critical for health care providers to form a concept for medical 
treatment and education for asthmatic populations to manage children's asthma 
symptoms.        
Emergency Department Visit 
 Children with asthma who do not effectively use an inhaler during asthma attacks 
or episodes may encounter difficulties controlling asthma and may need to seek 
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emergency treatment more frequently. Patients may be required to visit the ED more 
frequently due to poor asthma management and control (Storms, Tringale, & Ferro, 
2015). Effective interventions help address asthma symptoms; however, there are more 
asthma-related ED visits than primary care visits in children with asthma (Celik, Araz, 
Bastani, & Saenz, 2017). In the United States, asthmatic children are more likely to visit 
the ED and require hospitalization than older adults (Al-Muhsen et al., 2015). Patients 
need a higher level of asthma management if they have been hospitalized because of 
asthma exacerbations (Basheti, Obeidat, & Reddel, 2018). When a high-risk population 
of asthma patients visits the hospital because of asthma episodes or attacks, they will be 
educated and provided with self-management skills to control asthma symptoms (Basheti 
et al., 2018). Educating the patients at every hospital visit, particularly on inhaler 
technique skills, is vital as incorrectly operating an inhaler device leads to more ED visits 
in children (Carpenter et al., 2016). Effective asthma education is critical for asthmatic 
children because it reduces hospital admissions, improves functionality, and achieves 
more positive health status (Grover et al., 2016). In a previous study, Ali et al. (2019) 
showed that providing asthma education with patients one at a time is associated with 
asthma control, fewer ED visits, and fewer hospital admissions. Administering 
prophylactic inhaled corticosteroids has been shown to reduce the severity of the 
problem, but without appropriate guidelines on how to use the medication effectively, it 
can cause a relapse of symptoms (Ali et al., 2019). It is still unclear whether a lack of 
knowledge impacts the delivery of medication and the occurrence of exacerbations and 
ED visits. In the previous study, researchers did not have sufficient information about 
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whether a child's age can be a factor during inhalation regardless of if a child was 
instructed by a healthcare professional (Ali et al., 2019). Several research findings 
revealed that not providing credible asthma education to the asthmatic population may 
lead to poor asthma control, and symptoms may prolong (Ali et al., 2019). The 
insufficient information to explain the association between asthma education and drug 
delivery may make it difficult to manage asthma attacks or episodes, and the asthma 
patient might continue to develop severe medical complications. 
Inhaler Device  
 An inhaler is the method of medication delivery in the lungs for asthmatic 
children. The goals of the inhaler devices are to control asthma symptoms and alleviate 
risks. Inhaler devices are the primary route to administer adequate drugs in the airways to 
treat asthma (Pessôa et al., 2018). According to Gillette et al. (2016), inhaler devices are 
the preferred medication delivery method in asthma straight to the lungs. However, if the 
appropriate number of doses is not inhaled, there is a likelihood that a child may 
experience asthma episodes or attacks, especially when it is inadequate for breathing 
during the inhalation (Zoltan, 2015). The inhaled treatment has many positive impacts on 
treating asthma because of the high delivery concentration of the drug straight to the 
airways with a few side effects, but demonstrating incorrect technique turns to the 
inefficacy of treatment (Türkeli, Yılmaz, & Yüksel, 216). The inhaler devices continue to 
affect asthma outcomes, and an inhaler device is becoming an essential choice for asthma 
control medication (Gillette et al., 2016). Asthma can be controlled more effectively 
when the children use an inhalation technique correctly (Gillette et al., 2016). Inhalers are 
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crucial tools to immediately treat asthma exacerbation and control for patients with 
persistent asthma (Ali et al., 2019). A child is expected to have the ability to correctly use 
the inhaler device as it is known to be an essential factor for successful asthma treatment 
(Juntunen-Backman et al., 2015). However, patients continue to misuse an inhaler device 
even though they were trained on the correct technique (Aydemir, 2015). Adherence to 
the proper procedures may reduce asthma attacks or episodes. Operating the inhalation 
techniques properly could also reduce visiting the emergency room. For long-term 
treatment, the inhalation devices might be an appropriate tool to use for asthma 
management; however, the device's effectiveness depends on how the inhalation 
technique is performed (Mebrahtom, Mesfin, Gebreyesus, & Teweldenmedhin, 2019). 
Incorrectly using an inhalation technique can substantially reduce treatment effectiveness 
(Mebrahtom et al., 2019). Some evidence has indicated that misusing an inhaler can 
cause only a small amount of medication to be delivered to the lungs (Mebrahtom et al., 
2019). However, it is not clear if this is also due to the absence of a spacer attached in an 
inhaler. Misusing an inhaler device decreases drug delivery, and the patients may 
encounter consequences with asthma health complications (Almomani, Mokhemer, Al-
Sawalha, & Momany, 2018). Inadequate drug delivery to the lungs can be the result when 
patients do not operate an inhalation device correctly, causing the prevalence rate of 
asthma to rise consistently (Kovačević et al., 2018). Patients may still perform the 
inhalation techniques poorly, even after instructions (Kilgore, Al Katranji, Woodall, 
Shepherd, and Flesher, 2016; Jat et al., 2016). Previous studies have indicated that a lack 
of controlling asthma might be in part due to the improper usage of the inhaler devices 
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(Kilgore et al., 2016).  Nevertheless, previous researchers did not state if using spacers 
would improve the drug delivery regardless if the patients incorrectly operated the inhaler 
devices or missed a few steps in sequence.  
Asthma Education 
Researchers have suggested that 67% of health care providers are unable to 
demonstrate the correct inhaler technique to their patients (Kilgore et al., 2016; Root & 
Small, 2019). An inhalation device is a standard route to administer asthma drugs, but 
few health care professionals have the competence to teach the technique to their patients 
(Velasco et al., 2015). When a pharmacist provides education regarding the proper use of 
an inhaler in children, it improves the symptoms and inhaler technique and decreases the 
number of ED visits and hospitalizations (Zarmouh, 2019). When health care 
professionals deliver the instructions to patients, the adherence and inhaler technique 
improve in children, but the ED visits, hospitalizations, and symptoms remain the 
concern (Zarmouh, 2019). This indicates that a patient’s use of an inhalation technique 
depends on how it was taught, and, therefore, poorly controlling asthma is not solely 
because of how it was performed or the absence of a spacer with an inhaler. The practical 
education or instruction on how to operate an inhaler seems to depend on who provides 
the materials. It is unclear whether the pharmacists or other healthcare professionals 
should disseminate information on effectively performing the inhalation technique to 
better control asthma in children. Although a correct inhaler technique seems 
understandable and easy to follow, many patients tend to forget the inhaler vocal training 
they have received (Al Ammari et al., 2017). 
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 The factors to unsuccessfully control asthma are a lack of education about the 
correct inhaler technique, and the learning process is complex to adhere to several 
asthmatic children (Ali et al., 2019). The lack of knowledge about asthma, inadequate 
inhaler training, and low level of health literacy impacts a patient’s ability to operate an 
inhaler accurately (Axtell, Haines, & Fairclough, 2017). Many inhaler devices users may 
experience discouragement because of a lack of benefit from treatment (Jat et al., 2016).  
 The patients or parents might have received training about the correct use of 
inhalers by a professional. However, if these audiences do not understand the information 
provided, it may be a factor to incorrectly operating an inhaler with or without a spacer. 
The patients or parents of patients who do not understand the health information provided 
for the proper use of the medication may improperly administer the drug resulting in the 
worsening of asthma symptoms severity and increase the rate of hospitalizations (Yin et 
al., 2019). Health care providers often identify the appropriate inhaler device for their 
patients and are knowledgeable enough to teach their patients the correct inhaler 
technique; however, they may overlook assessing the level of proficiency (Kshatriya, 
Khara, Paliwal, & Patel, 2016). In the event of an asthma attack or episode, the first 
selection of the method to treat it is the metered-dose inhaler (Ozkars & Kirik, 2019). 
There are some cases that it may prove difficult to learn the proper technique of 
medication use (Ozkars & Kirik, 2019). The medication will not reach the airways and 
may prove ineffectual if children do not use the inhaler incorrectly (Ozkars & Kirik, 
2019). Aside from using an inhaler correctly, a tool called the “spacer” attached to an 
inhaler could prevent the medication from escaping and more of the medicine deposited 
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in the lungs. When children encounter difficulties in using inhaler devices, the result may 
decrease adherence, resulting in ineffective drug delivery. The researchers in the previous 
study discussed several effective inhalers to use to treat asthma with the proper inhalation 
technique instructions to treat asthma. However, it is unclear whether this method has 
reduced the symptoms and prevalence of asthma in the children population, specifically 
ages seven to 12 years old.    
Spacers 
 Using spacers with an inhaler may be beneficial to improving drug delivery in the 
lungs. The spacers might have the features that allow most of the medications to be 
inhaled through the lungs by requiring the patient to coordinate the actuation and 
breathing sequence. A spacer attached to an inhaler device may increase the deposition of 
drugs in the lungs if the patients provide adequate coordination of inspiration (Guilbert et 
al., 2017). The inspiratory flow rates are a critical factor in inhaling the appropriate 
amount of drug delivery (Haidi et al., 2016). Failure to perform hand-breath coordination 
can fail to deliver an adequate amount of medication into the lung with in-breath (Sanders 
& Bruin, 2015). Young asthmatic children should utilize an inhaler with a spacer to 
prevent insufficient coordination compared to older asthmatic children should use a dry 
powder inhaler device with a proper breathing sequence (Pinto, Jeri, & Barbosa, 2018). 
Insufficient hand-breath coordination or inspiratory flow rate may influence during the 
inhalation procedures, and fewer drugs deliver through the lungs (Vandewalker, Hickey, 
& Small, 2017). Schoessler and Winders (2016) also stated that a spacer does not suspend 
the medication in the air, but it holds the drug in the chamber. Schor et al. (2017) further 
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stated that spacers could reduce the requirement for hand-breath coordination and 
enhance lower airways by improving the efficacy of dose inhalers in delivering 
medications.  
 An inhaler without a spacer provides a smaller number dose of the treatment to 
the airway; some medications stay on the tongue, and the rest may be wasted into the air 
(Babaei, Najafi, Khosh Boo, & Ghesmati, 2018). Using a spacer with an inhaler prevents 
drugs from escaping in the air and improves drug penetration into peripheral airways 
(Schor et al., 2017). Some studies have shown that using spacers with different inhalers 
such as pressurized metered-dose inhalers (pMDIs) may result from increasing the total 
amount of drug available for inhalation (Guilbert et al., 2017).  
 Childhood asthma is most likely to occur in the preschool years, and for this age 
group, the MDI treatment will principally be to administer with a spacer (Topal et al., 
2018). The previous study has shown that MDI treatment with a spacer will be the 
appropriate treatment for asthmatic children. However, it is unclear whether the particular 
children’s population received formal instruction or help from their parents during the 
inhalation and whether asthma episodes or attacks have occurred after the treatment. A 
health care provider might need to reinforce asthmatic children to use spacers with an 
inhaler to administer medications regardless of the type of drugs being inhaled. Kilgore et 
al. (2016) added that using a spacer is beneficial because it increases the likelihood of 
health improvement and reduces symptoms. Asthma treatments should be administered 
throughout periods of well-being to avoid attacks or episodes in children (Aslam, Shakir, 
& Murray, 2016). The desired health outcome is not feasible to achieve if the children 
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continue to administer medication incorrectly. Children that failed to comply with the 
asthma management plan resulted in poor asthma control and risk developing severe 
chronic health conditions. 
 Children not using a spacer on an inhaler significantly decrease the effectiveness 
of aerosol therapy of children, increasing the risk of complications (Newhouse & Amirav, 
2019). Several factors lead to poor asthma control, including a poor understanding of 
multiple inhalers use, a lack of spacer availability, and social stigmatization (Ammari et 
al., 2017). Based on the previous studies, the medications administered by a health care 
professional indicated some improvement in controlling asthma and reduced ED visits as 
well as hospitalizations (Ellis et al., 2019). There are several critical steps to follow when 
delivering asthma drugs using an inhaler that cannot be missed because it impacts the 
number of medications inhaled into the lungs, and asthma symptoms may be challenging 
to treat as a result. When the misuse of an inhaler occurs, it may significantly increase the 
incidence and prevalence rate of asthma in children. Misusing an inhaler might also lead 
to the severity of the health problem. The researchers did not provide sufficient 
information about medication delivery, whether the amount of an inhaler with the 
appropriate medical care can obtain asthma control. There are several inhalers to 
administer medications to treat asthma and have been accepted widely. Unfortunately, the 
researchers on the previous studies do not further discuss the rationale as to why children 
continue to control asthma very poorly and develop symptoms even if this population 
received the appropriate professional instructions on how to deliver drugs using an 
inhaler, whether using a spacer.  
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 The researchers did not investigate whether using a spacer with an inhaler would 
improve the delivery of Albuterol (+ A. Sulfate or Salbutamol) to the lungs and 
improving control of asthma symptoms in all children. Although a spacer prevents the 
treatment from evaporating, it is unclear whether the rate of inspiratory influences the 
drug delivery in the lungs; without new approaches or directions to address the health 
problem, asthma may develop severe health complications in children and remains an 
important concern in the field of public health.   
Definitions  
 The amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled whether using an 
inhaler is the dependent variable, and age and asthmatic children are the independent 
variables for the first research question. The asthma severity is the dependent variable, 
and inhalation technique instruction during asthma episode or attack, age, and asthmatic 
children are the independent variables for the second research question. 
Albuterol (+ A. Sulfate or Salbutamol): A medication to treat asthma. Albuterol 
(+ A. Sulfate or Salbutamol) is a glucocorticoid used to treat allergies, inflammation, and 
prevent worsening of asthma through inhaled or injection (Reggie, Neimkin, & Holds, 
2018).    
Asthma control: Published guidance provided by a physician for patients to 
adhere to asthma attacks or episodes occurs. The use of asthma treatment reduces the 
symptoms and lessens the duration of an asthma attack or episodes (Akiki et al., 2019).  
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Asthma knowledge: Patients received asthma education provided by a professional 
about the steps need to execute in case of asthma attacks. According to Luckie et al. 
(2018), asthma education is a verbal or written instruction by a medical practitioner.   
Asthma symptom control: Inhaling medications to control asthma symptoms and 
treat airway inflammation. A respiratory disease increasing the risk of developing 
asthma, or the asthmatic condition becomes progressively worse (Grosso et al., 2019).  
Asthmatic children: A population of children (seven-12) years old with asthma. A 
group of asthmatic children may represent an allergic airway inflammation (Licari, 
Fuchs, Marseglia, & Ciprandi, 2019).   
Chronic obstructive pulmonary disease (COPD): A lung disease that prevents 
airflow and causes shortness of breath. COPD is an inflammation, persistent airflow 
limitation, and mucous obstruction (Atanasova & Reznikov, 2018).   
Current asthma: An individual diagnosed with asthma by a primary care 
physician and shows symptoms such as wheezing, nocturnal chest tightness, attack of 
shortness of breath, or medication use for breathing problems (Akiki et al., 2019).  
Healthcare professional: Multidisciplinary team involved in direct patient care of 
asthmatic children. Healthcare professionals include nurses, primary care physicians, 
respiratory therapists, pharmacists, pediatricians, pharmacy technicians, and other clinic 
personnel licensed to provide care and treatment to asthmatic patients (Plaza et al., 2018).    
Inhalation technique: A tool that is designed to deliver asthma medications in the 
human body. Sufficient amounts of drugs are distributed in the lungs when performing an 
inhalation technique correctly (Gregoriano et al., 2018).  
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Inhaler: Is a controller medication, which is the mainstay of the management of 
persistent asthma (Ferro et al., 2019).  
Instructional mode (education): A published instruction provided by a health 
provider that guides the usage of an inhaler when administering medications. 
Instructional materials guide asthmatic patients to manage asthma and enhance learning 
performance (Moussa-Inaty, Atallah, & Causapin, 2019 
Spacers: A tube that attaches to the inhaler and holds medication that assists get 
the medications into the lungs. A spacer is a tool attached to an inhaler to prevent drugs 
from escaping in the air to deliver adequate drugs (Ming et al., 2019).  
Quality of life: Changes the health status of children negatively due to asthma 
symptoms, attacks, or episodes. Asthma symptoms can lead to an asthma attack that 
impairs the population's quality of life (Crossman-Barnes, Sach, Wilson, & Barton, 
2019).   
Assumptions 
 The participants provided appropriate and sufficient information in response to 
the survey questionnaires of the secondary data. Thus, the inclusion criteria are relevant 
and assure that the participants have all encountered the symmetrical phenomenon of the 
study. These assumptions were necessary for the context of the study because it is 
imperative to develop meaningful results that answer the research questions leading to 
developing the appropriate recommendation for future research of the phenomenon and 
social change.  
22 
 
Scope and Delimitations  
Scope of the Study 
 Asthma remains to be the primary concern in public health that disrupts the health 
of children. An insufficient amount of medication delivered into the lungs due to 
improper usage of an inhaler with or without spacers results in difficulties controlling 
asthma outcomes. Therefore, the prevalence and incidence rate of asthma in children is 
continuously stationary. Focusing on these aspects to provide solutions and identify 
effective interventions to a health issue is imperative. Following an intervention 
effectively mitigates the factors that cause a long period of asthma attacks or episodes, 
and the children may achieve their desired positive health outcome as a result.  
Delimitations  
 The study consisted of asthmatic children, ages seven to 12 years old. It included 
children who have been administered with various asthma medications such as Albuterol 
(+ A. Sulfate or Salbutamol) with an inhaler technique, whether using spacers. The study 
excluded older adults as well as children ages 1 to 6 and thirteen and up. The population 
that does not have a history of an asthma attack was excluded from the investigation.   
Significance  
The results of this study provided new insights and filled in the gaps in the 
literature that address the problem and health issue of children with asthma. This study 
also addressed the gaps by articulating the effect of inhalation of Albuterol (+ A. Sulfate 
or Salbutamol) using with or without spacers in children with asthma to improve the 
outcome of asthma and quality of life for children. Further, the findings may contribute to 
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the evidence-based practice to reevaluate and modify the health policy to ensure that 
decisions, plans, and actions that occur achieve the goals in health care within a society. 
My research findings provided essential insights, thus, identifying the practical 
approaches to help alleviate the risk factors and prevent the development of the health 
issue. The results may trigger an increased awareness of the health issue in public health 
that will change individuals’ behavior leading to developing effective decisions to 
achieve their desired health outcome. The results allow creating an intervention that will 
reduce the new incidence rate of the health issue and reduce the burden about the health 
issue in the field of public health. The comprehensive new insights from this study will 
benefit social change, such as maintaining and promoting a positive health outcome in the 
children population.  
Summary  
Asthma is a chronic disease that constricts the lungs' airways and develops health 
complications such as shortness of breath, chest tightness, and coughing. Asthma remains 
the health issue in the field of public health that practitioners need to mitigate. There are a 
considerable amount of studies pertaining to asthmatic children. The previous studies 
have provided a piece of in-depth information on the risk factors, causes, symptoms, 
prevention, and asthma medications. However, there is insufficient evidence as to what, if 
there is a relationship between the amount of Albuterol (+ A. Sulfate or Salbutamol) 
whether using a spacer delivered in the lungs. At the same time, a healthcare provider 
provides users with proper instructions. Using an inhaler with or without a spacer, 
improperly affects the amount of asthma medication delivered in the lungs. Therefore, 
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asthmatic children will not be treated medically and encounter difficulties in obtaining 
the desired health outcome. This study focused on investigating the association of 
Albuterol (+ A. Sulfate or Salbutamol) with or without a spacer in children with asthma. 
Also, it investigated if the severity of asthma among children depends on the improper 
usage of the inhalation technique during administering medications. It was imperative to 
conduct this study to fill the literature gaps and develop a new conceptual framework to 
address asthma in the population. The findings of the study promote social change in the 
population and enhance the knowledge of healthcare providers leading to improving the 
medication delivery method to improve health and reduce the new incidence rate of the 
children.  
Conclusion 
Asthma, regardless of cause, is an often-chronic disease, and one that remains a 
significant concern to public health. Asthma is associated with adverse effects on 
children's health, and it is critical to investigate and identify solutions that reduce these 
adverse health effects. It remains imperative to investigate the complexity of these 
associated problems to determine effective solutions. Doing so will improve children's 
health and reduce the severity of the development of asthma in the population. The result 
of the study added information in the literature and provided additional knowledge on 
how to manage or control asthmatic children. The findings of this study have shown 
effective strategies exist for the target population, and health care providers and 
adherence to these strategies are critical in reducing the effects of asthma attacks, by 
extension, reducing the frequency of visits to ED. The results of this study provided new 
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insights that have promoted positive social change, providing a more in-depth 
understanding of asthma that children, parents, and health professionals can add to best 
practices in maintaining positive health status. 
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Section 2: Research Design and Data Collection 
Introduction 
 The purpose of this study was to investigate the association of an Albuterol (+ A. 
Sulfate or Salbutamol) inhaler with and without spacers in children with asthma. In 
Section 1, I discussed the various effects of asthma in the target population and 
worldwide. This study was important to identify if the amount of medication delivered in 
the lungs with or without a spacer precipitates an asthma attack or episode. Through this 
research, I explored if the severity of asthma in children has a relationship with the 
instructions provided by a professional when administering drugs using an inhaler device. 
Overall, the results of this study can be used to develop innovative approaches to improve 
the delivery of medication and how to effectively use an inhaler, whether used with or 
without a spacer. 
Research Design and Rationale  
 For the first research question, the dependent variable was the number of canisters 
of Albuterol (+ A. Sulfate or Salbutamol). The independent variable was Albuterol (+ A. 
Sulfate or Salbutamol) with or without a spacer. For the second research question, the 
dependent variable was the duration of asthma episodes or attacks in children, and the 
independent variable was with or without an inhalation technique instruction given by a 
professional.  
 In this quantitative research study, I used a cross-sectional design. The research 
design allowed me to further investigate the association of the amount of medication 
delivery with or without a spacer in the children population. I also identified the 
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association between the duration of asthma episodes or attacks and children with and 
without an inhalation instruction provided by a health care professional in the age group 7 
to 12.  
Methodology 
Population 
 This study involved asthmatic children ages 7 to 12 years old. The Behavioral 
Risk Factor Surveillance System (BRFSS) Asthma Call-Back Survey (ACBS) collected 
data in all 50 states, including the District of Columbia and the U.S. territories (Centers 
for Disease Control and Prevention [CDC], 2015).  In the 2015 child landline-cell phone 
combined data file, there were 1,146 records from nine states and Puerto Rico. 
Sampling and Sampling Procedures  
 The BRFSS performed data collection in each state in the United States using a 
telephone survey system tailored to the individual’s health risk factors, chronic diseases, 
and available preventative services (CDC, 2015). The BRFSS is partnered with the CDC 
to receive assistance in technical and methodological aspects by having interviewers and 
contractors with telephone call centers or universities in the state health department to 
conduct the BRFSS surveys throughout the year (CDC, 2015).  
 As far as the BRFSS ACBS questionnaire components, each state in the United 
States was mandated to use the published standard core questionnaires, modules, and 
stated questions. Random digit dialing techniques on both landlines and cell phones 
execute surveys during the data collection (CDC, 2015). The questionnaires in the 
surveys and any modifications to the questionnaires needed approval from the BRFSS 
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state coordinators and the CDC before it could be published. A proposal needed to be 
submitted if the BRFSS desired to add new questions in the questionnaires (CDC, 2015). 
Each state coordinator who submits a proposal requires presenting a rationale that 
supports the questions. The CDC (2015) requires each state coordinator to provide an 
explanation that supports the questions in the proposal, which are the (a) original 
question, (b) history of prior cognitive, (c) validity testing, (d) history of prior use, and 
(e) analytical plan. Most importantly, the proposed questions need to comply with the 
primary and secondary criteria related to a Healthy People 2020 objective or concern 
health issue and the needs of the stated department (CDC, 2015). There are different 
stages that the BRFSS states coordinators will undergo before approving the new 
questions in the questionnaires, which are (a) a technical review, (b) cognitive testing, 
and (c) field testing (CDC, 2015).  
 The BRFSS used poststratification as the statistical weighting method because the 
number of interviews within each state might differ according to the funding and size of 
regions – health districts. The age, sex, ethnicity, states, marital status, education level, 
homeownership, and type of phone ownership were the variables used to weight BRFSS 
data.    
 The data produced by federal agencies are accessible in public and may be 
reproduced without prior permission. However, it is necessary to ensure and critical to 
acknowledge that the CDC’s BRFSS is the original source for the materials or data 
published in public. The Annual Survey Data section, comprehensive materials, data 
files, codebooks, design documents, and methodology are on the BRFSS’s website. 
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Data Collection  
 Data collection for the ACBS included the use of both landline and cellphone 
(LLCP) samples, which were the required protocols in each state. Each state possesses a 
BRFSS interview schedule and expects to administer all calls for a given survey month 
within a similar sample month. It is possible to make up to 15 calling attempts for each 
phone number in the sample; however, state regulations must adhere to calling. The 
BRFSS (2019) protocols claimed that the five calling occasions to consider when 
conducting surveys are (a) to perform 20% of the interviews on weekdays, (b) to hold 
80% on weeknights and weekends, (c) to note that schedules may be modified in 
observance to holidays and special events, (d) to make weekday calls just after the dinner 
hour, and (e) to make appointment call-backs during hours that are not scheduled for 
other interviews. ACBS collected data for the child from 26 states/territories. The child 
LLCP, who met data quality standards from the states/territories that performed both 
LLCP samples from 10 states/territories for the child data are available in public. The 
ACBS questionnaires were published in English and are available in Spanish. An adult 
aged 18 must be present to take a survey and is a proxy to the child.  
Inclusion Criteria 
 The states that participated in the child LLCP ACBS in the year of 2015 and are 
included in the data and released in public are Connecticut, Kansas, Michigan, 
Minnesota, New Jersey, Ohio, Utah, and Puerto Rico. 
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Exclusion Criteria  
 The data that were gathered through LLCP samples from California, Georgia, 
Hawaii, Indiana, Maine, Massachusetts, Mississippi, Missouri, Montana, New 
Hampshire, New Mexico, New York, Oklahoma, Oregon, Pennsylvania, Rhode Island, 
Vermont, and Wisconsin were excluded because these states accumulated less than 75 
records and thus were ineligible to produce reliable weights. Also, Florida, Illinois, Iowa, 
and Nevada did not collect child ACBS data. Florida did not collect cellphone data in 
January, February, March, and April 2015. The among weighted states with no record of 
ACBS participation in the LLCP data for children, including Minnesota, Nebraska, New 
Jersey, Texas, Utah, more than 10% were not included in the data. The modified 
adjustment factor method was used for these states for weighting purposes.   
Power Analysis  
 To identify the required sample size for my study, I used the G*Power3 software. 
The G*Power3 software is used to determine the appropriate sample size for statistical 
analyses (Gignac & Szodorai, 2016). Using the G*Power3 analysis, the sample t tests, 
with effect size 0.5, alpha level 0.05, and power 0.95, a sample size of 176 was 
necessary. The power analysis occurs in the research process as well as during data 
analyses (Pek & Park, 2019). The power analyses are responsible for identifying the 
smallest sample size that is appropriate to detect the effect of the test statistics (Pek & 
Park, 2019). The study results relied on statistical power, and having a low sample size 
may cause a higher number of false negatives, false positives, or inability to show 
association (see Gjerdevik et al., 2019). Incorporating the Power*G3 software to identify 
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the sample size in my research study was an essential component in the data analysis in 
order to answer the research questions.   
Instrumentation and Operationalization of Constructs  
The secondary data were accessed from the CDC – ACBS that was conducted 
from 2006 to 2015 as part of the BRFSS. The BRFSS-ACBS data published in 2015 were 
used as the secondary data, which were accessed in the public database. However, 
permission to use the data was submitted to the CDC before accessing the codebook. The 
ACBS used the appropriate instruments for the current study as it collected information 
about chronic diseases, medications, socioeconomic status, behavioral, and 
environmental predictors that relate to better control of asthma. 
Operationalization   
 There were two dependent variables in this research study: the amount of 
Albuterol (+ A. Sulfate or Salbutamol) inhaled and asthma duration (Table 1). There 
were three independent variables: age-group, Albuterol (+ A. Sulfate or Salbutamol) with 
or without a spacer, and professional inhalation instruction (Table 2). The independent 







Variables Measurement  Survey question  Data values or 
units 
Number of canisters 




Ratio  How many canisters of 
[medication’s name] has 
[child’s name] used in the 




Asthma duration  Ratio  During the past three 
months, how many asthma 
episodes or attacks has 
[he/she] had? 
None, don’t 




Independent Variables  
Variables  
 





Ordinal  Child asthma call-back age 
group questionnaire 
Age 0-6, age 7-
12, age 13-17 
 
Albuterol (+ A. 
Sulfate or 
Salbutamol) with or 
without a spacer 
 
Nominal  Does [he/she] use a spacer 
with [medication’s name]? 
Yes, no  
Professional inhaler 
instruction  
Nominal  Did a health professional 
show [him/her] how to use 
the inhaler? 







Data Analysis Plan  
 Statistical Package for Social Sciences (v 25) by IBM was used to perform data 
analyses for the asthma call-back survey 2015 data. Before performing data analyses, it is 
necessary to execute data cleaning and implementing screening procedures by examining 
the data thoroughly for entry error, to ensure that the data correctly reflects the responses 
provided by the participants, identify missing data and ensure that the variables needed to 
answer the research questions are included in the data. Since this was quantitative 
research, cleaning the data entailed identifying missing data from the data entry, which 
can be detected from the frequencies of the variable. During the data screening, it was 
vital to identify a pattern to the missing data, if any, double entries, outliers, and 
unreported results. Missing values were detected in the data, and therefore, a 
transformation feature was utilized to address them; likewise, the sample was sufficient 
for my study.  
The data analysis was intended to answer the following research questions below 
and accept or reject hypotheses:  
Research Question (RQ)1-Quantitative: What is the association between the 
amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers 
among children 7 to 12 years old? 
H01: There is no significant statistical association between the amount of Albuterol 
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to 
12 years old.  
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H1:  There is a significant statistical association between the amount of Albuterol 
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to 
12 years old. 
Research Question (RQ)2-Quantitative: What is the association between the 
number of asthma episodes or attacks with or without professional inhalation 
instruction on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in 
children 7 to 12 years old? 
H01: There is no association between the number of asthma episodes or attacks 
 with or without professional inhalation instruction on the proper delivery of 
 Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old. 
H02: There is an association between the number of asthma episodes or attacks 
with or without professional inhalation instruction on the proper delivery of 
Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old. 
Statistical Analysis  
 The statistical analysis was quantitative research involved descriptive statistics 
that demonstrated the frequency counts, ranges (high and low values), means, modes, 
median, and standard deviation. This particular test provided a summation of the sample 
and measures (Ho & Yu, 2015). The quantitative data are typically demonstrated as 
frequency distribution or relative frequency rather than percentage; the upper and lower 
limits will depend upon the size of the data (Kulkarni, 2016).  
 The first research question consisted of a dependent variable, the amount of 
Albuterol (+ A. Sulfate or Salbutamol) inhaled. The independent variable was with or 
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without a spacer. The second research question included a dependent variable, the 
number of asthma episodes or attacks. The independent variables included with or 
without a professional inhalation instruction on proper delivery of Albuterol (+ A. Sulfate 
or Salbutamol) and age-group (7-12).  A sample t test was used to test the hypotheses and 
identify the association of the two variables. A sample t test was appropriate as it 
compared two groups and performed a comparison of characteristics of two variable 
groups (Plonsky, 2015). The sample size for the experimental and control groups is 
essential when using t tests in a study (Kim & Park, 2019). Using this particular test was 
imperative to identify the association by comparing the dependent and independent 
variables.   
Threats to Validity 
 The BRFSS-ACBS within the CDC collects data for samples by administering the 
survey in the population as well as intending to be generalizable. Westreich, Edwards, 
Lesko, Cole, & Stuart (2018) stated that an external validity revolves around the 
generalizability of findings beyond the experimental context. External validity may arise 
as a problem if a study sample is not tailored to the target population or cannot assume 
the actual association in a study sample will be the exact effect in the population 
(Westreich et al., 2018). The confounding factors, nonexchangeability for 
generalizability, and nonrepresentative of a target population are the potential threats to 
this particular validity (Westreich et al., 2018). Confounding or covariate factors are the 
potential threats to external validity in my research study, including gender, proficiency 
level, and ethnicity of the child.    
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 Internal validity determines whether causation can be inferred from the statistical 
conclusions (Richardson, Dalton, Shafer, and Patterson, 2016). This form of validity can 
be threatened by those similar threats to statistical conclusion validity and other 
assessment factors, including altering the instrument over time or test exposure 
(Richardson et al., 2016). Confounding factors and selection biases can threaten internal 
validity (Westreich et al., 2018). The study employs a cross-sectional design, which does 
not apply to internal validity because the causal relationships cannot be certainly proven.  
 Statistical conclusion validity determines the accuracy of inference about the 
presence and strength of the relationship between two variables (Richardson et al., 2016). 
Additionally, it can be threatened by measurement limits (e.g., restricted range), 
measurement error (e.g., unreliability), incorrectly applied statistics, unreliable treatment 
implementation, and other sources of variance introduced into the experimental setting as 
well as by low statistical power (Richardson et al., 2016). These threats can increase the 
chance of Type 1 or Type II error or the additional error called Type III error by some 
concluding significance or non-significance when in fact, the assessments or the 
treatments were not correctly implemented (Richardson et al., 2016).  
Ethical Procedures 
 The ethical concern with the BRFSS with ACBS data was that the Institutional 
Review Board (IRB) required that asthma should be discussed with the participants 
during an interview process in some states, and other states do not require asthma to be 
disclosed. The interviewers must be attentive with the consent informed or a code number 
on file before a survey can be administered. A code one (1) is indicated on the file, in 
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which the state does require action to link the responses from the two interviews. 
Otherwise, ACBS cannot be performed, and there will be no record on file if consent was 
denied.      
 Permission request was submitted to the CDC to utilize the ACBS data conducted 
in 2015 within the BRFSS. The CDC provided instructions on obtaining a public data file 
tailored to asthma data in children. The Walden University Institutional Review Board 
(IRB number: 07-16-20-0741112) has approved my doctoral study to use the ACBS data 
conducted in 2015 in the CDC to perform data analyses. My research data and the ACBS 
data focused on the children’s population. According to Joshua, Zwi, Moran, & White 
(2015), vulnerable children group experience several obstacles to health care, which 
include sub-optimal access compounded by social disadvantage and culture or linguistic 
barriers, were not aware of care services are being offered, and capacity to use them, 
insufficient awareness by health providers of their complex health needs. However, an 
18-year or older adult is required to take the questionnaires of the survey for the child. 
Therefore, it does not fall onto the vulnerable children group.   
Summary 
In section 2, I discussed the cross-sectional research design in the study to 
investigate further the statistically significant association between the variables at the 
0.05 significance level. This study tailored to asthmatic children ages 7 to 12, and data 
was extracted from the BRFSS – ACBS within the CDC published in 2015. The survey 
dataset was analyzed using SPSS (v.25) and performed descriptive analysis, frequencies, 
and sample t tests.  
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Section 3: Presentation of the Results and Findings 
Introduction  
 The primary purpose of the research study was to thoroughly investigate the 
association between the amount of inhalation of Albuterol (+ A. Sulfate or Salbutamol) 
and the use of spacers among 7 to 12-year-old children with asthma. In Section 3, I 
provide the results of the statistical analyses and the presentation of findings in tables and 
figures. Additionally, I demonstrate the different components of the data collection for 
the BRFSS ACBS dataset that was conducted in 2015. This section involves the answers 
to the research questions as follows:  
Research Question (RQ)1-Quantitative: What is the association between the 
amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers 
among children 7 to 12 years old? 
H01: There is no significant statistical association between the amount of Albuterol 
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to 
12 years old.  
H1:  There is a significant statistical association between the amount of Albuterol 
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to 
12 years old. 
Research Question (RQ)2-Quantitative: What is the association between the 
number of asthma episodes or attacks with or without professional inhalation 
instruction on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in 
children 7 to 12 years old? 
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H01: There is no association between the number of asthma episodes or attacks 
 with or without professional inhalation instruction on the proper delivery of 
 Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old. 
H02: There is an association between the number of asthma episodes or attacks 
with or without professional inhalation instruction on the proper delivery of 
Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old. 
Data Collection of Secondary Data Set 
Data collection for the ACBS and the use of both LLCP samples were the 
required protocols in each state. ACBS collected data for children from 26 
states/territories. The child LLCP who met data quality standards from the 
states/territories using both LLCP samples from 10 states/territories for the child data 
were available in public. The ACBS questionnaires were published in English and were 
available in Spanish. An adult aged 18 or above had to be present to take a survey and 
was a proxy to the child. 
Timeframe for Data Collection 
The ACBS undergoes a pilot study each year, which is a comprehensive asthma 
survey administered in 50 states, the District of Columbia, and participating territories 
with BRFSS using both landlines and cellphones. The BRFSS has discovered a new 
approach to identify respondents with asthma to expand interviewing on a call-back 
basis. Thus, it included a larger sample size in each area. States typically follow a 
suggested BRFSS interviewing schedule and complete all calls for a given survey month 
within a similar sample month. There are up to 15 calling attempts that may be made for 
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each phone number in the sample, but it depends on state regulations for calling and 
outcomes of previous calling attempts. The data are available within 6 months from the 
end of the calendar year of data collection.   
Response Rate  
The BRFSS respondents who reported ever being diagnosed with asthma were 
eligible for the asthma call-back. The weighting methodology for the BRFSS was 
changed significantly, and cell phone samples were added to the traditional landline 
phone samples. The number of states or territories that respond in the ACBS has 
increased each year. However, ACBS follows a rule of not reporting or interpreting point 
estimates based on fewer than 50 unweighted respondents. 
Demographic Characteristics of the Sample  
Tables 3, 4, and 5 display the demographic information of the sample in the study. 
The study involved N = 416 participants aged 7 to 12 years with a diagnosis of asthma. 
Boys (n = 243) represented 58.4% and girls (n = 172) represented 41.3%. These 
individuals lived in Connecticut (10.3%), Kansas (15.4%), Michigan (9.1%), Minnesota 
(11.3%), Nebraska (9.4%), New Jersey (13.5%), Ohio (4.6%), Texas (7.5%), Utah 
(11.1%), and Puerto Rico (7.9%). As part of the screening process, these children's 
parents were interviewed to determine if their child would be eligible for the study. 
Because this is a vulnerable population, an 18-year-old or older must be present at the 
interview time for completion. This study involved children 7 to 12 years old who were 







State of Child  
State Frequency Percent Valid percent Cumulative percent 
 Connecticut 43 10.3 10.3 10.3 
Kansas 64 15.4 15.4 25.7 
Michigan 38 9.1 9.1 34.9 
Minnesota 47 11.3 11.3 46.2 
Nebraska 39 9.4 9.4 55.5 
New Jersey 56 13.5 13.5 69.0 
Ohio 19 4.6 4.6 73.6 
Texas 31 7.5 7.5 81.0 
Utah 46 11.1 11.1 92.1 
Puerto Rico 33 7.9 7.9 100.0 




Child Age Age-Group Call-Back 
Age Frequency Percent Valid percent Cumulative percent 




Gender of Child 
Gender Frequency Percent Valid percent Cumulative percent 
 Boy 243 58.4 58.4 58.4 
Girl 172 41.3 41.3 99.8 
Refused 1 .2 .2 100.0 





Results of the Study 
The chi-square test was applied to test the association between two variables. If 
the chi-square test rejects the null hypothesis, then there is an association between the 
two variables, which means that there is a statistical association between the two 
variables (Zhu & Fang, 2016). Testing for association between two variables is routinely 
performed in statistical applications, and Pearson’s Ch-Sq statistic is widely applied to 
the test if both variables of interest are ordinal or continuous to measure the association 
(Shih & Fay, 2017). I used Cramer’s V test to evaluate and measure the strength of the 
association between the amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or 
without spacers among children for the first research question as well as the association 
between the number of asthma episodes or attacks and with or without a professional 
inhalation instruction on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in 
children ages 7 to 12. Cramer’s V test and Phi solely confirmed an association between 
the two variables, the direction of an association, the strength of an association, and the 
statistical significance of the association between the independent and dependent 
variables found in this study. Amran, Zaaba, Singh, and Marashih (2017) stated that the 
independent variable could be classified as the variable that cannot be changed for the 
result. In contrast, the dependent variable can be classified as the variable that can be 
changed for the result.  
Statistical Assumptions  
The chi-square assumptions, including the data in the cells, have frequencies or 
counts of cases rather than percentages or some other transformation of the data. The 
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levels of the variables are mutually exclusive, and thus, a particular subject fits into one 
and only one level of each of the variables. There are two variables both measured at the 
nominal and ordinal levels.  
Research Question (RQ)1-Quantitative: What is the association between the 
amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers 
among children 7 to 12 years old? 
The expected count is what I would expect to observe if there was no association. 
In table 6 and figure 1, I would expect 20 participants have used a spacer, 11 participants 
did not use a spacer, and 0.4 participants indicated that medication has a built-in spacer or 
does not need a spacer with zero number of canisters inhaled. I would expect 49 
participants have used a spacer, 37 did not use a spacer, and one has indicated that 
medication has a built-in spacer or does not need a spacer with one number of canisters 
inhaled. I would expect 11 children have used a spacer, 32 did not use a spacer, and one 
has stated that medication has a built-in spacer or does not need a spacer with the amount 
of two canisters inhaled. I would expect ten children used a spacer, six did not use a 
spacer, and 0.2 indicated that medication has a built-in spacer or does not need a spacer 
with the amount of three canisters inhaled. I would expect 0.6 children used a spacer, 0.4 
did not use a spacer, and zero of the participants indicated that medication has a built-in 
spacer or does not need a spacer with the amount of 4 canisters inhaled I would expect 
0.6 children used a spacer, 0.4 did not use a spacer, and zero of the participants indicated 
that medication has a built-in spacer or does not need a spacer with the amount of five 
canisters inhaled. I would expect 0.6 children used a spacer, 0.4 did not use a spacer, and 
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zero of the participants indicated that medication has a built-in spacer or does not need a 
spacer with the amount of eight. I would expect two children used a spacer, one child did 
not use a spacer, and zero of the participants indicated that medication has a built-in 






Albuterol (+ A. Sulfate or Salbutamol) Medication With or Without a Spacer 
 
 
Albuterol (+ A. sulfate or salbutamol: if spacer used 
Total Yes No 
Medication has a built-in spacer/does not 
need a spacer 
Albuterol (+ A. sulfate or salbutamol): 
Number of canisters 
0 Count 23 11 0 34 
Expected 
Count 
20.4 13.2 .4 34.0 
1 Count 43 37 2 82 
Expected 
Count 
49.1 31.9 1.0 82.0 
2 Count 12 7 0 19 
Expected 
Count 
11.4 7.4 .2 19.0 
3 Count 11 5 0 16 
Expected 
Count 
9.6 6.2 .2 16.0 
4 Count 1 0 0 1 
Expected 
Count 
.6 .4 .0 1.0 
5 Count 1 0 0 1 
Expected 
Count 
.6 .4 .0 1.0 
8 Count 0 1 0 1 
Expected 
Count 
.6 .4 .0 1.0 
12 Count 3 0 0 3 
Expected 
Count 
1.8 1.2 .0 3.0 
Total Count 94 61 2 157 
Expected 
Count 
94.0 61.0 2.0 157.0 
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Figure 1 shows the number of canisters inhaled whether a spacer is used among children 
aged 7 to 12 years.  
 
Figure 1. The number of canisters inhaled whether a spacer is used among children aged 
7 to 12 years.  
47 
 
In table 7, the chi-square test, X2 = 9.479, p = .799. The statistical test tells us that 
there is no significant statistical association between the amount of the Albuterol (+ A. 
Sulfate or Salbutamol) inhaled with or without spacers among children ages seven to 12 
years old. We accept the null hypothesis and reject the alternative hypothesis. 
Table 7 
 
Chi-Square Tests  
 Value df Asymptotic significance (2-sided) 
Pearson Chi-Square 9.479a 14 .799 
Likelihood ratio 12.275 14 .584 
Linear-by-linear association 1.201 1 .273 
N of valid cases 157   
a. 16 cells (66.7%) have expected count less than 5. The minimum expected count is 
.01. 
 Table 8 shows the strength of the association between the amount of the 
Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 







Nominal by nominal Phi .246 .799 
Cramer's V .174 .799 











Research Question (RQ)2-Quantitative: What is the association between the 
number of asthma episodes or attacks with or without professional inhalation 
instruction on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in 
children 7 to 12 years old? 
 The expected count is what I would expect to observe if there was no association. 
In table 9 and figure 2, I would expect 340 children received professional inhaler 
instruction, 11 did not receive professional inhaler instruction, and two children who did 
not know if they received professional inhaler instruction with zero asthma episodes or 
attacks. I would expect 100 children received professional inhaler instruction, three 
children did not receive professional inhaler instruction, and 0.7 did not know if they 
have received professional inhaler instruction with 1 number of asthma episodes or 
attacks. I would expect 63 children received professional inhaler instruction, two did not 
receive professional inhaler instruction, and 0.4 did not know if they have received 
professional inhaler instruction with two asthma episodes or attacks. I would expect 28 
children received professional inhaler instruction, 0.9 did not receive professional inhaler 
instruction, and 0.2 did not know if they have received professional inhaler instruction 
with three asthma episodes or attacks. I would expect 13 children received professional 
inhaler instruction, 0.4 did not receive professional inhaler instruction, and 0.1 did not 
know if they have received professional inhaler instructions who had four asthma 
episodes or attacks. I would expect 14 children received professional inhaler instruction, 
0.4 did not receive professional inhaler instruction, and 0.4 did not know if they have 
received professional inhaler instruction, which had five asthma episodes or attacks. I 
49 
 
would expect 12 children received professional inhaler instruction, 0.4 did not receive 
professional inhaler instruction, and 0.1 did not know if they have received professional 
inhaler instruction, which had six asthma episodes or attacks. I would expect five 
children received professional inhaler instruction, 0.2 did not receive professional inhaler 
instruction, and zero of the participants indicated that they do not know if they have 
received professional inhaler instructions who had seven asthma episodes or attacks. I 
would expect two children received professional inhaler instruction, 0.1 did not receive 
professional inhaler instruction, and zero of the participants indicated that they do not 
know if they have received a professional inhaler, which had eight asthma episodes or 
attacks. I would expect one child received professional inhaler instruction, zero children 
did not receive professional inhaler instruction, and zero of the participants indicated that 
they do not know if they have received a professional inhaler, which had nine asthma 
episodes or attacks. I would expect six children received professional inhaler instruction, 
0.2 did not receive professional inhaler instruction, and zero of the participants indicated 
that they do not know if they have received a professional inhaler, which had ten asthma 
episodes or attacks. I would expect one child received professional inhaler instruction, 
zero children did not receive professional inhaler instruction, and zero of the participants 
indicated that they do not know if they have received professional inhaler instruction, 
which had fifteen asthma episodes or attacks. I would expect three children received 
professional inhaler instruction, 0.1 did not receive professional instruction, and zero of 
the participants indicated that they do not know if they have received professional inhaler 
instruction, which had twenty asthma episodes or attacks. I would expect two children 
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received professional inhaler instruction, 0.1 did not receive professional inhaler 
instruction, and zero of the participants indicated that they do not know if they have 
received a professional inhaler instruction that had thirty asthma episodes or attacks. I  
would expect one child received professional inhaler instruction; zero of the participants 
did not receive professional instruction, and zero of the participants indicated that they do 
not know if they have received professional inhaler instruction, which had forty asthma 
episodes or attacks. I would expect one child received professional inhaler instruction; 
zero of the participants did not receive professional instruction, and zero of the 
participants indicated that they do not know if they have received professional inhaler 
instruction, which had sixty asthma episodes or attacks. I would expect two children 
received professional inhaler instruction, 0.1 did not receive professional inhaler 
instruction, and zero of the participants indicated that they do not know if they have 




The Number of Episodes or Attacks and Professional Inhaler Instruction 
 
Professional inhaler instruction 
Total Yes No Don't know 
Number of episodes/attacks 0 Count 340 11 2 353 
Expected Count 339.8 10.9 2.3 353.0 
1 Count 104 0 0 104 
Expected Count 100.1 3.2 .7 104.0 
2 Count 62 3 0 65 
Expected Count 62.6 2.0 .4 65.0 
 
3 
Count 25 3 1 29 
Expected Count 27.9 .9 .2 29.0 
4 Count 13 0 0 13 
Expected Count 12.5 .4 .1 13.0 
5 Count 14 0 0 14 
Expected Count 13.5 .4 .1 14.0 
6 Count 11 1 0 12 
Expected Count 11.6 .4 .1 12.0 
7 Count 5 0 0 5 
Expected Count 4.8 .2 .0 5.0 
8 Count 2 0 0 2 
Expected Count 1.9 .1 .0 2.0 
9 Count 1 0 0 1 











Professional inhaler instruction 
Total Yes No Don't know 
Number of episodes/attacks 10 Count 5 1 0 6 
Expected Count 5.8 .2 .0 6.0 
15 Count 1 0 0 1 
Expected Count 1.0 .0 .0 1.0 
20 Count 3 0 0 3 
Expected Count 2.9 .1 .0 3.0 
30 Count 2 0 0 2 
Expected Count 1.9 .1 .0 2.0 
40 Count 1 0 0 1 
Expected Count 1.0 .0 .0 1.0 
60 Count 1 0 0 1 
Expected Count 1.0 .0 .0 1.0 
90 Count 1 0 1 2 
Expected Count 1.9 .1 .0 2.0 
Total       Count         591   19 4 614 




Figure 2 shows a bar chart of the number of episodes or attacks and 
whether the children received professional inhaler instruction.  
 
Figure 2. The number of asthma episodes or attacks if a professional inhaler instruction 
was provided.  
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In table 10, the chi-square test, X2 = 95.541, p = .000. The statistical test tells us 
that there is an association between the number of asthma episodes or attacks and with or 
without a professional inhalation instruction on proper delivery of Albuterol (+ A. Sulfate 
or Salbutamol) in children ages seven to 12 years old. We reject the null hypothesis and 
accept the alternative hypothesis.   
Table 10 
Chi-Square Tests  
 Value df Asymptotic significance (2-sided) 
Pearson Chi-Square 95.541a 32 .000 
Likelihood ratio 27.806 32 .679 
Linear-by-linear Association 39.926 1 .000 
N of valid cases 614   
a. 42 cells (82.4%) have expected count less than 5. The minimum expected count is 
.01. 
 
In table 11, we can see that the strength of the association between the number of 
asthma episodes or attacks and with or without a professional inhalation instruction on 
proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in children ages 7 to 12 years 





 Value Approximate significance 
Nominal by nominal Phi .394 .000 
Cramer's V .279 .000 





The first research question intends to investigate the association between the 
amount of the Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers 
among children ages seven to 12 years old. It was found that there is no significant 
statistical association between the amount of the Albuterol (+ A. Sulfate or Salbutamol) 
inhaled with or without spacers among children ages seven to 12 years old. Therefore, we 
fail to reject the null hypothesis and reject the alternative hypothesis. The phi and 
Cramer's V test indicated that the association between the variables is weak. The second 
question intends to investigate the association between the number of asthma episodes or 
attacks with or without a professional inhalation instruction on proper delivery of 
Albuterol (+ A. Sulfate or Salbutamol) in children ages seven to 12 years old. The result 
of this study showed that there is an association between the number of asthma episodes 
or attacks and with or without a professional inhalation instruction on proper delivery of 
Albuterol (+ A. Sulfate or Salbutamol) in children ages seven to 12 years old. Therefore, 
we reject the null hypothesis and accept the alternative hypothesis. The phi and Cramer's 
V test indicated that the association between the variables is strong. While section 3 has 
demonstrated the statistical analysis findings, section 4 discussed the interpretation of the 
findings in-depth, limitations of the study, and recommendations.  
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Section 4: Application to Professional Practice and Implications for Social Change  
Introduction  
The primary purpose of this research study was to thoroughly investigate the 
association between the amount of inhalation of Albuterol (+ A. Sulfate or Salbutamol), 
whether or not using a spacer. I also examined the association between the number of 
asthma episodes or attacks with or without professional inhalation instruction on the 
proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old. 
The nature of this study was a cross-sectional research design data analysis that was 
conducted using Statistical Package for the Social Sciences (v.25) Software. Using 
quantitative research for this study allowed me to develop numerical data that provided 
in-depth information that supports generalizations related to the phenomenon under 
study. I found that there is no significant statistical association between the amount of 
Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 
ages 7 to 12. Additionally, I found that there is an association between the number of 
asthma episodes or attacks with or without professional inhalation instruction on the 
proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in children ages 7 to 12. 
Interpretation of the Findings  
The first research question tested the association between the amount of 
inhalation of Albuterol (+ A. Sulfate or Salbutamol), whether using a spacer, in children 
ages 7 to 12. The association between the amount of Albuterol (+ A. Sulfate or 
Salbutamol) inhaled with or without spacers among children ages 7 to 12 was not 
statistically significant (p > 0.05). The strength of association between the amount of 
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Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers was weak based 
on the phi and Cramer’s V test. Therefore, the number of doses inhaled in the lungs does 
not depend on with or without a spacer. Previous studies have shown that using spacers 
with an inhaler device is beneficial to improve drug delivery in the lungs as well as 
prevent the medication from escaping in the air (Pessôa et al., 2018). A spacer is intended 
to help the lungs absorb the appropriate amount of dose for effective treatment 
(Farahbakhsh, 2020). However, the findings in this study do not align with the previous 
studies. The findings of this study do not confirm whether using a spacer increases the 
chance for the medication to be inhaled in the lungs.  
The second research question tested the association between the number of 
asthma episodes or attacks with or without professional inhalation instruction on the 
proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in children ages 7 to 12. The 
association between the number of asthma episodes or attacks with or without 
professional inhalation instruction on the proper delivery of Albuterol (+ A. Sulfate or 
Salbutamol) in children ages 7 to 12 was statistically significant (p < 0.05). Phi and 
Cramer’s test indicated that the strength of association between the number of asthma 
episodes or attacks with or without professional inhalation instruction on the proper 
delivery of Albuterol (+ A. Sulfate or Salbutamol) was strong. When children between 
the ages of 7 and 12 receive professional inhaler instructions, they are more likely not to 
have asthma episodes or attacks. The children may have fewer visits to the ED as a result 
of this observation. 
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On the other hand, if children do not receive professional inhaler instruction, they 
may not know what to do during asthma episodes or attacks, and there is a higher 
likelihood that they visit the ED for clinical evaluation and treatment. This result shows 
the importance of receiving professional inhaler instruction to effectively manage asthma 
to decrease the number of asthma episodes or attacks. The results imply a critical need for 
children to learn the proper way to use an inhaler device to control their asthma 
symptoms from a professional to reduce asthma episodes or attacks and ED visits. In 
Table 9, (N = 340), children received professional inhaler instruction, which had 0 asthma 
episodes or attacks. N = 1 indicated “yes” received professional inhaler instruction, N = 
0.1 indicated “no” did not receive professional inhaler instruction, and N = 0.0 indicated 
that children who “do not know” if they received professional inhaler instruction; they 
had 90 asthma episodes or attacks. 
The statistical test in Table 9 revealed that the more professional inhaler 
instruction children received, the less they experienced asthma episodes or attacks. In 
contrast, the children who did not receive professional inhaler instruction were more 
likely to experience several asthma episodes or attacks. Previous studies revealed that the 
effectiveness requires that patients use an inhalation device with a proper technique, and 
health care providers must have firm skills to use inhalation devices in order to teach 
their patients effectively (Kellman, Iserson, Levy, McIntosh, & Maxwell, 2020). Most 
patients who visit the ED with asthma do not have adequate exposure to asthma 
education (Losappio et al., 2019). However, the findings of my analysis in this study are 
aligned with the literature in finding that the leading cause for children to visit the ED 
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may occur due to not being able to operate an inhaler device properly when asthma 
episodes or attacks happen.  
Application of Transtheoretical Change or Stages of Change 
The theoretical framework that was applied in this study was transtheoretical 
change or stages of change. The transtheoretical change model was used to examine an 
individual’s readiness to take action on a new behavior to improve their health. The 
process of behavioral change involves five stages of change, including precontemplation, 
contemplation, preparation, action, and termination (Keshmiri et al., 2017). Children 
must be provided with relevant information by their parents or health care providers 
about asthma and to recognize the symptoms of asthma to take actions to manage asthma 
immediately effectively. Children must be educated and provided with guidance on the 
proper use of an inhaler device for the sufficient amount of medication inhaled into the 
lungs to reduce asthma episodes or attacks and ED visits. Based on the results of this 
study, the transtheoretical model or stages of change imply that the children need to 
understand the medical complications of asthma, and they must take the appropriate 
actions. Changing their behavior may be essential to manage asthma effectively by firmly 
adhering to the instructions on how to use inhaler devices to maximize the appropriate 
amount of medication inhaled in the lungs to decrease the number of asthma episodes or 
attacks.  
Limitations of the Study  
The limitations identified in this study included that the primary variables to test 
for an association did not have values, and the variables associated in this study presented 
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a large number of missing values as a sample of 176 was necessary. This factor may have 
significantly affected the results as to whether there is an association between the amount 
of the Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers among 
children ages 7 to 12.  
Recommendations  
Further study is needed to conduct an in-depth exploration of how the age of a 
child may influence the way they use an inhaler device properly, with or without a 
spacer. There is a need for further research to identify a recommendable treatment plan 
for a patient with asthma who has coronavirus disease 2019 (COVID-19). Researchers 
need to further examine the efficacy of the interventions on managing asthma to help 
reach the desired health outcome. There is a need for further investigation on whether 
children are more likely to adhere to instructions provided by pharmacists and other 
clinicians. For children who inhaled the appropriate amount of medication but do not 
show improvement, it may be necessary to look at other factors, such as a history of 
asthma or an underlying medical complication. It may also be necessary to research if 
children are receiving information in their preferred learning style on how to use an 
inhaler properly. Future researchers could also look at if children with a high number of 
asthma attacks or episodes receive educational materials from their health care providers. 
Researchers could also examine if the amount of medication inhaled in the lungs depends 
on a spacer or medication with a built-in spacer without professional instruction. Another 
future research question may be if it is more effective when a pharmacist provides 
education on asthma management and the proper use of inhaler devices to a child rather 
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than other clinicians. It may also be necessary to evaluate and focus on the asthma 
treatment guidelines to align patient care at the policy level. There is a significant impact 
when a pharmacist includes training on asthma control to children as they focus on the 
asthma action plan and equip them with additional resources to better provide care for 
children with asthma (Kovačević et al., 2018). Improperly using an inhaler medication 
can lead to poor asthma management, leading to adverse outcomes. Deeks et al. (2018) 
stated that pharmacists have demonstrated that they can improve asthma control by 
increasing the appropriate use of medication.  
Implications for Professional Practice and Social Change 
Professional Practice 
Clinics, hospitals, and pharmacies need to have current guidelines for managing 
asthma. Professional clinicians should be competent and have broad knowledge about 
asthma and the use of inhaler devices. Providers must commit to continuing education on 
asthma to enhance their skills and expertise to implement the interventions for managing 
asthma effectively. With minimal training, pharmacists would be able to perform a device 
training educational session to all patients with asthma with the outcome of 
improvements in asthma management (Basheti A., Salhi, Basheti M., Hamadi, & Al-
Oerem, 2019). There is a confirmatory that poor inhaler technique contributes to poor 
management and loss of asthma control with children requiring to take reliever 
medications (Goodwin & Heraghty, 2015). There are at least 25% of children with 
asthma who do not receive any verbal instructions on how to use their inhaler devices 
sufficiently (Goodwin & Heraghty, 2015). For those who do, the quality and duration of 
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instructions are often insufficient (Goodwin & Heraghty, 2015). All types of care 
providers need to provide the highest quality care service to their inpatient and outpatient 
children to ensure that expectations are met (Park, G., Park, K., & Agarwal, 2016). It may 
be essential for clinical facilities to develop and implement some other ways to deliver 
instructions on how to use inhaler devices correctly in children. The methods of teaching 
aligned with children’s learning styles may increase their adherence to the guidelines 
because they may have a better understanding of the whole sequence steps.  
Social Change  
The results of this study serve to develop a positive social change at an individual, 
family, community, organization, and policy levels. The results transform into a positive 
social change in human interactions as they become more aware of asthma and attain the 
critical interventions to adhere to control asthma effectively. The parents and relatives 
may become more aware of the problems that will increase their commitment to guiding 
their children throughout the asthma treatment to improve symptoms. Additionally, the 
parents and relatives will provide social support and commit to counseling their child 
who has asthma by following the clinicians' guidelines to improve poor asthma outcomes. 
The parents of children with asthma may also become a representative member of a 
community to offer a forum to discuss the new insights found within the individuals at 
large to encourage them to take action for the health improvement of their children with 
asthma.  
 The results of this study signify the need for health policymakers to reevaluate 
the guidelines of clinics to ensure that they stay current with the instructions for asthma 
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management. Also, the clinics must ensure to be equipped with educational materials 
about asthma that align with the needs of patients with asthma to maximize the efforts to 
reach their desired health outcome. Ultimately, healthcare providers must take immediate 
action after learning new insights about the importance of using inhaler devices correctly 
to alleviate the number of children admitted to the ED or hospitalization rate.   
Conclusion  
Children with asthma remain to be a problem in the field of public health that 
needs to mitigate. Asthma contributes to adverse health outcomes that limit a child’s 
daily activities and even increase school absenteeism. An inhaler device is a standard 
medication treatment for asthma with or without a spacer. A spacer is a tool that can be 
attached to the inhaler device to help doses from escaping in the air, if operated correctly, 
according to a previous study. This research found that there is no significant statistical 
association between the amount of the Albuterol (+ A. Sulfate or Salbutamol) inhaled 
with or without spacers among children ages seven to 12 years old when examining the 
association between the amount of the Albuterol (+ A. Sulfate or Salbutamol) inhaled 
with or without spacers among children ages seven to 12 years old. Additionally, this 
study also investigated the association between the number of asthma episodes or attacks 
and with or without a professional inhalation instruction on proper delivery of Albuterol 
(+ A. Sulfate or Salbutamol) in children ages seven to 12 years old and it has found that 
there is an association between the number of asthma episodes or attacks and with or 
without a professional inhalation instruction on proper delivery of Albuterol (+ A. Sulfate 
or Salbutamol) in children ages seven to 12 years old. The association between the 
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amount of the Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers 
among children ages seven to 12 years old was less clear. However, the statistical 
significance between the number of asthma episodes or attacks with or without a 
professional inhalation instruction on proper delivery of Albuterol (+ A. Sulfate or 
Salbutamol) in children ages seven to 12 years old confirmed the findings from the 
previous studies. When children do receive professional inhaler instructions, they are 
most likely not to have asthma episodes or attacks, leading to fewer visits to the ED. 
Subsequently, if children do not receive professional inhaler instruction, they are most 
likely to not know what to do during asthma episodes or attacks.  As a result, there is a 
likelihood that they will visit the ED for treatment. This study of the phenomenon 
warrants further research to deeply explore the effectiveness of the interventions for 
controlling asthma as well as to investigate if there are other factors such as underlying 
medical conditions that may prohibit the patients from recovering or worsening asthma 
symptoms. The results of the study warrant a positive social change at an individual, 
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